The emergence of lipid nanoparticles as nucleic acid delivery vehicles has revolutionized medicine, with polyethylene glycol (PEG)-lipids playing a crucial role in particle formation and in vivo fate. However, PEG has been linked to immune responses that can provoke side effects and may prevent repeat dosing, and so PEG alternatives are now being developed. Here we argue that, rather than concentrating on PEG replacement, the field should prioritize designing around pre-existing immune memory.
- Namit Chaudhary
- Kathryn A. Whitehead